Kwangdong Healthbio Co., Ltd. (XKON:086220)

Market Cap	17.72B +6.1%
Revenue (ttm)	38.10B -2.5%
Net Income	-323.52M
EPS	-57.00
Shares Out	12.69M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	81
Average Volume	783
Open	1,399.00
Previous Close	1,400.00
Day's Range	1,252.00 - 1,399.00
52-Week Range	1,120.00 - 1,719.00
Beta	-0.10
RSI	49.06
Earnings Date	n/a

About Kwangdong Healthbio

Kwangdong Healthbio Co., Ltd. manufactures and sells functional health and general food, and cosmetic products. The company offers functional health food products for applications in the areas of intestines, immunity, blood circulation, cognitive ability improvement, cavity, blood sugar control, anti-oxidation, memory improvement, prostate health, fatigue improvement, joint/bone health, skin care, liver health, calcium absorption, cholesterol, blood pressure control, eye care, ergogenic ability improvement, body fat, neutral fat in blood, relax...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 81
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 086220

Financial Performance

In 2014, Kwangdong Healthbio's revenue was 38.10 billion, an increase of 19.85% compared to the previous year's 31.79 billion. Losses were -323.52 million, -15.02% less than in 2013.